Immunotherapy and endothelin receptor antagonists for treatment of castration-resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immunotherapy and endothelin receptor antagonists for treatment of castration-resistant prostate cancer

Published:2013-04-08 Issue:7 Volume:133 Page:1743-1750
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Shao Ning¹,Wang Yang²,Jiang Wen Yu³,Qiao Di¹,Zhang Shi Ge¹,Wu Ye¹,Zhang Xiang Xiang¹,Wang Jiu Ling¹,Ding Yi¹,Feng Ning Han⁴

Affiliation:

1. Department of Urology; Jiangsu Province Geriatric Hospital; Nanjing; China

2. Department of Urology; First Affiliated Hospital of Nanjing Medical University; Nanjing; China

3. Department of Gastroenterology; First Affiliated Hospital of Nanjing Medical University; Nanjing; China

4. Department of Urology; Second People's Hospital of Wuxi; Nanjing Medical University; Wuxi; China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. Cancer statistics, 2012;Siegel;CA Cancer J Clin,2012

2. Estimates of cancer incidence and mortality in Europe in 2008;Ferlay;Eur J Cancer,2010

3. Epidemiology of castration resistant prostate cancer: a longitudinal analysis using a UK primary care database;Hirst;Cancer Epidemiol,2012

4. Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer;Halabi;J Clin Oncol,2003

5. Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group;Scher;J Clin Oncol,2008

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A tumour‐associated macrophage‐based signature for deciphering prognosis and immunotherapy response in prostate cancer;IET Systems Biology;2024-08-13

2. Development and validation of [18 F]-PSMA-1007 PET-based radiomics model to predict biochemical recurrence-free survival following radical prostatectomy;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-01

3. Establishing a Prognostic Model in Prostate Adenocarcinoma through Comprehensive scRNA-Seq and Bulk RNA-Seq Analysis and Validation;2024-02-02

4. An endoplasmic reticulum stress-related signature featuring ASNS for predicting prognosis and immune landscape in prostate cancer;Aging;2024-01-10

5. A review focusing on the role of pyroptosis in prostate cancer;Medicine;2023-12-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3